RTS, S was the first vaccine to exploit VLP as a vaccine carrier, this chimeric VLP was generated by directly fusing malaria antigen circumsporozoite protein (CSP) to HBsAg and co-expressed the fusion protein with native HBsAg in a 1:4 ratio in Saccharomyces cerevisiae. Here, DNAJC5 is linked to malaria.